205 related articles for article (PubMed ID: 3490495)
1. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells.
Kawamura N; Muraguchi A; Hori A; Horii Y; Mutsuura S; Hardy RR; Kikutani H; Kishimoto T
J Clin Invest; 1986 Nov; 78(5):1331-8. PubMed ID: 3490495
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
5. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
Shimizu K; Hirano T; Ishibashi K; Nakano N; Taga T; Sugamura K; Yamamura Y; Kishimoto T
J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.
Yoshizaki K; Nakagawa T; Fukunaga K; Kaieda T; Maruyama S; Kishimoto S; Yamamura Y; Kishimoto T
J Immunol; 1983 Mar; 130(3):1241-6. PubMed ID: 6600479
[TBL] [Abstract][Full Text] [Related]
7. B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes.
Muraguchi A; Nishimoto H; Kawamura N; Hori A; Kishimoto T
J Immunol; 1986 Jul; 137(1):179-86. PubMed ID: 3486912
[TBL] [Abstract][Full Text] [Related]
8. Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).
Pistoia V; Cozzolino F; Torcia M; Castigli E; Ferrarini M
J Immunol; 1985 May; 134(5):3179-84. PubMed ID: 3920315
[TBL] [Abstract][Full Text] [Related]
9. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
10. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a human B cell line that proliferates in response to B cell growth factor.
Abe H; Rossio JL; Ruscetti FW; Matsushima K; Oppenheim JJ
J Immunol Methods; 1986 Jun; 90(1):111-23. PubMed ID: 2423613
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
Ledbetter JA; Shu G; Gallagher M; Clark EA
J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
[TBL] [Abstract][Full Text] [Related]
13. T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.
Thompson CB; Schaefer ME; Finkelman FD; Scher I; Farrar J; Mond JJ
J Immunol; 1985 Jan; 134(1):369-74. PubMed ID: 3917279
[TBL] [Abstract][Full Text] [Related]
14. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
Suzuki T; Butler JL; Cooper MD
J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
Richard Y; Leprince C; Dugas B; Treton D; Galanaud P
J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.
Benjamin D; Bazar LS; Wallace B; Jacobson RJ
Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061
[TBL] [Abstract][Full Text] [Related]
17. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia.
Fournier S; Jackson J; Kumar A; King T; Sharma S; Biron G; Rubio M; Delespesse G; Sarfati M
Eur J Immunol; 1992 Jul; 22(7):1927-30. PubMed ID: 1623931
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of an early activation marker restricted to human B cells.
Kikutani H; Kimura R; Nakamura H; Sato R; Muraguchi A; Kawamura N; Hardy RR; Kishimoto T
J Immunol; 1986 Jun; 136(11):4019-26. PubMed ID: 3084651
[TBL] [Abstract][Full Text] [Related]
20. Human cell lines secreting lymphokines. II. BCGF production by a T hybridoma and B cell lines.
Gozes Y; Epstein N; Halmann M; Bino T; Rosenberg H; Kobiler D
Dev Biol Stand; 1987; 66():447-55. PubMed ID: 3495463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
